1. Home
  2. TRT vs HBIO Comparison

TRT vs HBIO Comparison

Compare TRT & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRT
  • HBIO
  • Stock Information
  • Founded
  • TRT 1958
  • HBIO 1901
  • Country
  • TRT United States
  • HBIO United States
  • Employees
  • TRT N/A
  • HBIO N/A
  • Industry
  • TRT Industrial Machinery/Components
  • HBIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • TRT Technology
  • HBIO Industrials
  • Exchange
  • TRT Nasdaq
  • HBIO Nasdaq
  • Market Cap
  • TRT 22.5M
  • HBIO 19.6M
  • IPO Year
  • TRT N/A
  • HBIO 2000
  • Fundamental
  • Price
  • TRT $5.78
  • HBIO $0.45
  • Analyst Decision
  • TRT
  • HBIO Buy
  • Analyst Count
  • TRT 0
  • HBIO 2
  • Target Price
  • TRT N/A
  • HBIO $3.00
  • AVG Volume (30 Days)
  • TRT 29.5K
  • HBIO 1.2M
  • Earning Date
  • TRT 05-13-2025
  • HBIO 08-11-2025
  • Dividend Yield
  • TRT N/A
  • HBIO N/A
  • EPS Growth
  • TRT N/A
  • HBIO N/A
  • EPS
  • TRT 0.00
  • HBIO N/A
  • Revenue
  • TRT $35,548,000.00
  • HBIO $91,397,000.00
  • Revenue This Year
  • TRT N/A
  • HBIO N/A
  • Revenue Next Year
  • TRT N/A
  • HBIO $9.75
  • P/E Ratio
  • TRT $1,232.55
  • HBIO N/A
  • Revenue Growth
  • TRT N/A
  • HBIO N/A
  • 52 Week Low
  • TRT $4.62
  • HBIO $0.28
  • 52 Week High
  • TRT $7.88
  • HBIO $3.48
  • Technical
  • Relative Strength Index (RSI)
  • TRT 61.37
  • HBIO 49.68
  • Support Level
  • TRT $5.22
  • HBIO $0.39
  • Resistance Level
  • TRT $5.80
  • HBIO $0.48
  • Average True Range (ATR)
  • TRT 0.29
  • HBIO 0.03
  • MACD
  • TRT 0.04
  • HBIO -0.00
  • Stochastic Oscillator
  • TRT 97.06
  • HBIO 67.67

About TRT Trio-Tech International

Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

Share on Social Networks: